ID

34287

Description

Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01486966

Link

https://clinicaltrials.gov/show/NCT01486966

Keywords

Versions (1)
  1. 1/16/19 1/16/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 16, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes NCT01486966

English

Eligibility Diabetes NCT01486966

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01486966
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
Back to the top of the page

Similar models

Eligibility Diabetes NCT01486966

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01486966
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial